Eli Lilly and Co., which has faced thousands of suits over its anti-psychotic Zyprexa, says lawyers' ads about the drug are prompting patients to stop taking mental illness medications when they shouldn't. Results of a company-funded survey of 402 psychiatrists show that more than half said they believed that their patients who stopped or reduced their medication did so after seeing the commercials, which one critic said have an "ambulance-chasing feel to them."
June 14, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Eli Lilly and Co., which has faced thousands of lawsuits over its anti-psychotic Zyprexa, says lawyers’ ads about the drug are prompting some patients to stop taking mental illness medications when they shouldn’t.
The advertising blitz “presents yet another barrier for patients who suffer from severe mental illness” and increases the risks that people will not get the care they need, said Carole Puls, a spokeswoman for the Indianapolis-based drug maker.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
DESCRIPTION: The Metropolitan Transportation Authority ( MTA ) hereby solicits proposals from law firms, including sole practitioners, to pr...
The Partners Group is currently recruiting a VP of Legal for our burgeoning client, a real estate investment firm in Atlanta, GA. The firm h...
